Concomitant irradiation and dose-escalating carboplatin for locally advanced carcinoma of the uterine cervix: An updated report

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 1, 1998, Pages 31-35

  Corn, Benjamin W ^a   Micaily, Bizhan ^b   Dunton, Charles J ^a   Heller, Paul ^b   Valicenti, Richard K ^a   Anderson, Lisa ^b   Hernandez, Enrique ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Carboplatin; Cervix cancer; Radiotherapy

Indexed keywords

CARBOPLATIN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; DIARRHEA; DISEASE ASSOCIATION; DOSE RESPONSE; DYSURIA; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, HIGH-ENERGY; UTERINE CERVICAL NEOPLASMS;

EID: 0031940373     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199802000-00007     Document Type: Article

References (35)

1. Komaki R, Brickner TJ, Hanlon AL, et al. Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983: patterns of care study (PCS). Int J Radiat Oncol Biol Phys 1995;31:973-82.
2. 60cobalt gammastrahlen in humanen tumorzellinien in vitro. Strahlenther Onkol 1996; 167:244-9.
3. Corn BW, Hernandez E, Anderson L, et al. Phase I study of concomitant irradiation and carboplatin for locally advanced carcinoma of the uterine cervix: an interim report. Am J Clin Oncol 1996; 19:316-20.
4. Rubin P, Constine LS, Fajardo LF, et al. Joint statement of mission by the RTOG/EORTC working groups. Int J Radiat Oncol Biol Phys 1995;31:1037-9.
5. Montana GS, Hanlon AL, Brickner TJ, et al. Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. Int J Radiat Oncol Biol Phys 1995;32:1481-6.
6. Jones WB, Shingleton HM, Russell A, et al. Patterns of care for invasive cervical cancer: results of a national survey of 1984 and 1990. Cancer 1995;76:1934-47.
7. Souhami L, Gil RA, Allan SE. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIb carcinoma of the cervix. J Clin Oncol 1991;9:970-7.
8. Tattersall MHN, Lorvidhaya V, Vootrix V, et al. Randomized trial of epirubicin and ciplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 1995;3:444-51.
9. Thomas GM. Is neoadjuvant chemotherapy a useful strategy for the treatment of stage IB cervix cancer? Gynecol Oncol 1993;49:153-5.
10. Grigsby PW. Lack of proven efficacy of chemotherapy for patients with carcinoma of the uterine cervix. Seminars in Radiation Oncology 1994;4:30-3.
11. Stehman FB. Experience with hydroxyurea as a radiosensitizer in carcinoma of the cervix. Semin Oncol 1992; 19:48-52.
12. Thomas G, Dembo A. Carcinoma of the cervix. In: Horwich A, ed. Combined radiotherapy and chemotherapy in clinical oncology. London: Edward Arnold, 1994:150-164.
13. Perez CA, Kurman RJ, Stehman FB, et al. The cervix. In: Hoskins W, Young R, Perez CA, eds. Principles and practice of gynecologic oncology. Philadelphia: JB Lippincott, 1992:591-663.
14. McGuire WP, Arseneau J, Blessing JA, et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 1989;7:1462-8.
15. Filtenborg TA, Hansen H, Engelholm S, et al. A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix. Ann Oncol 1993;4:485-8.
16. Muggia FM, Gill I. Role of carboplatin in endometrial and cervical cancer. Semin Oncol 1992; 19:90-3.
17. Canetta R, Goodlow J, Smaldone L, et al. Pharmacologic characteristics of carboplatin: clinical experience. In: Bunn PA, Cannetta R, Ozols RF, et al., eds. Carboplatin: current directions and future perspectives. Philadelphia: WB Saunders, 1990:5-15.
18. Tamimi HK, Marit EK, Hesla J, et al. Glassy cell carcinoma of the cervix redefined. Obstet Gynecol 1988:71:837-41.
19. Prasasvinichai S, Glassburn JR, Brady LW. Treatment of recurrent carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1978;4:957-61.
20. Thomas GM, Rauth AM, Bush RS. A toxicity study of daily dose metronidazole with pelvic irradiation. Cancer Clin Trials 1980;3:223-30.
21. Perez CA, Breaux S, Madoc-Jones H, et al. Radiation therapy alone in treatment of the uterine cervix. II. Analysis of tumor recurrence. Cancer 1984;51:1393-1402.
22. Thoms WW, Eifel PJ, Smith TL, et al. Bulky endocervical carcinomas: a 23-year experience. Int J Radiat Oncol Biol Phys 1992;23:491-9.
23. Bonomi P, Blessing JA, Stehman FB, et al. Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1985;3:1079-85.
24. Piver MS, Barlow JJ, Vongtama V. Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix. Am J Obstet Gynecol 1977; 129:379-83.
25. Fyles A, Keane TJ, Barton M, et al. The effect of treatment duration in the local control of cervix cancer. Radioher Oncol 1992;25:273-9.
26. Girinsky T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993;27:1051-6.
27. Lanciano RM, Pajak TF, Martz K, et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns of care study. Int J Radiat Oncol Biol Phys 1993;25:391-7.
28. Perez CA, Grigsby PW, Castro-Vita H, et al. Carcinoma of the uterine cervix. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. lnt J Radiat Oncol Biol Phys 1995;32:1275-88.
29. Petereit DG, Sarkaria JN, Chappell R, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1301-7.
30. Runowicz CD, Wadler S, Rodriguez-Rodriguez L, et al. Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. Gynecol Oncol 1989;34:395-401.
31. Chang H, Lai C, Chen M, et al. Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: a pilot study. Gynecol Oncol 1992;44:182-8.
32. Drescher CW, Reid GC, Terada K, et al. Continuous infusion of low-dose 5-fluorouracil and radiation therapy for poor-prognosis squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1992;44:227-30.
33. Heaton D, Yordan E, Reddy S, et al. Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy. Gynecol Oncol 1990;38:323-7.
34. John M, Flam M, Sikic B, et al. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG study. Gynecol Oncol 1990;37:1-5.
35. Friedman LM, Furberg CD, DeMets DL, eds. Fundamentals of clinical trials, 2nd ed. Littleton, MA: PSG, 1985:35-42.